Medscape Psychiatry retweeted
Unlock the future of NTRK fusion-positive cancer care! From gene fusion testing 🧬 to targeted therapies 💊—learn how to personalize treatment 🧑⚕️ and collaborate across care teams 🤝.
@OncBrothers @DavidHongMD @DrJNaidoo #NTRK #ASCO25 xitter.cf/i/broadcasts/1OwxWXEZw…
Medscape Psychiatry retweeted
🔥 Let’s talk PBC-associated pruritus! Explore clinical data, assess patient burden, and boost your confidence in managing itch in practice. Don’t miss this #DDW2025 session! xitter.cf/i/broadcasts/1BdGYqdQY…
Medscape Psychiatry retweeted
🧠 Can PDTs transform schizophrenia care? Join us now for this live event and dive into the latest research, trial data, & patient selection strategies for digital therapeutics in managing negative symptoms #PsychUpdate25 xitter.cf/i/broadcasts/1jMJgkaZd…
Medscape Psychiatry retweeted
💥 Day 3 at #PsychUpdate25 is off to a powerful start!
@drjessigold opened with an honest and insightful keynote on burnout 🧠— plus practical tips to prevent it before it hits. 💬
A much-needed reminder to check in…
How are you really feeling? 💛 #ReigniteHealthcare
Medscape Psychiatry retweeted
⚡️ What a powerhouse session at #PsychUpdate25!
Leslie Citrome, MD, Brooke A. Kempf, PMHNP, and Sagar Parikh, MD just broke down the latest in #depression care — cutting-edge insights, real-world strategies, and big takeaways. 🧠💡
Who else is feeling inspired? #ReigniteHealthcare
Medscape Psychiatry retweeted
Come hang out in the exhibit hall and grab a book and write how you feel! #PsychUpdate25 #ReigniteHealthcare @MedscapeLIVE @MedscapePsych
RT @Medscape: 💥 WE ARE LIVE 📊 Explore the economic burden of schizophrenia & its current treatment limitations. Learn about the impact of u…
Medscape Psychiatry retweeted
Do you attend your patients' funerals? #MedTwitter
16%Yes
84%No
235 votes • Final results Medscape Psychiatry retweeted
AI is here. Is your practice ready? Join us for a live panel featuring insights from @EricTopol, @arjunmanrai, and Dr. Ted A. James as they delve into AI's role in diagnosis, treatment, precision medicine, and related areas. Register: ms.spr.ly/601490erY #MedTwitter
Medscape Psychiatry retweeted
Do you believe physicians should solicit donations from their patients?
17%Yes
83%No
322 votes • Final results Medscape Psychiatry retweeted
Is daily cannabis use safer than daily tobacco use?
42%yes
58%no
320 votes • Final results Medscape Psychiatry retweeted
A patient leaves you money in their will: Can you accept it? #MedTwitter
45%Yes
55%No
842 votes • Final results Medscape Psychiatry retweeted
Women with mental health issues are 50% more likely to give birth to a premature baby, according to a new study. ms.spr.ly/601593Dq7
Medscape Psychiatry retweeted
Even after accounting for sociodemographic factors, intellectual disabilities, and psychiatric diagnoses, #autism is associated with an 83% increased risk of #selfharm among females and a 47% increased risk among males.
ms.spr.ly/60159yUkS
Medscape Psychiatry retweeted
The FDA has approved the first oral agent specifically for postpartum depression, a condition that affects an estimated one in seven mothers in the United States. ms.spr.ly/60179Glax
Medscape Psychiatry retweeted
Excessive drinking during the COVID pandemic increased alcoholic liver disease deaths so much that the condition killed more Californians than car accidents or breast cancer. ms.spr.ly/6013g04EP
Medscape Psychiatry retweeted
Last week's FDA approval of the anti-amyloid lecanemab is being hailed by some #Alzheimers experts as a major advance; others are less certain and have concerns about the drug's efficacy, safety, and cost. ms.spr.ly/6019g0NIS
Medscape Psychiatry retweeted
🚨 Exciting announcement: MedscapeLIVE! is pleased to announce the launch of our new app. Users can register for events, stream videos with synchronized slides, access direct link claim credit, & more. Download:
iOS: ms.spr.ly/6014gxIjG
Android: ms.spr.ly/6015gxIjH
Medscape Psychiatry retweeted
We’re continuing the conversation on MedThreads 🧵See you there! threads.net/t/CuVhXeZJCrR/?i…















